全文获取类型
收费全文 | 9494篇 |
免费 | 848篇 |
国内免费 | 294篇 |
专业分类
耳鼻咽喉 | 73篇 |
儿科学 | 450篇 |
妇产科学 | 73篇 |
基础医学 | 1303篇 |
口腔科学 | 18篇 |
临床医学 | 1072篇 |
内科学 | 1458篇 |
皮肤病学 | 80篇 |
神经病学 | 271篇 |
特种医学 | 240篇 |
外科学 | 600篇 |
综合类 | 1787篇 |
现状与发展 | 1篇 |
一般理论 | 1篇 |
预防医学 | 2066篇 |
眼科学 | 49篇 |
药学 | 518篇 |
3篇 | |
中国医学 | 497篇 |
肿瘤学 | 76篇 |
出版年
2024年 | 11篇 |
2023年 | 118篇 |
2022年 | 200篇 |
2021年 | 364篇 |
2020年 | 393篇 |
2019年 | 262篇 |
2018年 | 294篇 |
2017年 | 296篇 |
2016年 | 348篇 |
2015年 | 390篇 |
2014年 | 610篇 |
2013年 | 633篇 |
2012年 | 543篇 |
2011年 | 617篇 |
2010年 | 427篇 |
2009年 | 431篇 |
2008年 | 444篇 |
2007年 | 460篇 |
2006年 | 405篇 |
2005年 | 382篇 |
2004年 | 342篇 |
2003年 | 299篇 |
2002年 | 205篇 |
2001年 | 205篇 |
2000年 | 194篇 |
1999年 | 154篇 |
1998年 | 126篇 |
1997年 | 132篇 |
1996年 | 104篇 |
1995年 | 154篇 |
1994年 | 136篇 |
1993年 | 108篇 |
1992年 | 103篇 |
1991年 | 102篇 |
1990年 | 118篇 |
1989年 | 95篇 |
1988年 | 80篇 |
1987年 | 70篇 |
1986年 | 53篇 |
1985年 | 59篇 |
1984年 | 32篇 |
1983年 | 16篇 |
1982年 | 22篇 |
1981年 | 16篇 |
1980年 | 12篇 |
1979年 | 13篇 |
1978年 | 17篇 |
1977年 | 10篇 |
1976年 | 15篇 |
1975年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 656 毫秒
1.
[摘要] 目的 对发热伴血小板减少综合征(severe fever with thrombocytopenia syndrome, SFTS)的相关文献进行文献计量学和可视化分析,探寻近年来的研究现状、热点及趋势,为临床治疗和基础研究提供参考。方法?以Web of Science(WOS)核心合集和中国知网(China national knowledge infrastructure, CNKI)数据库为文献来源,检索2011年1月1日—2021年12月31日有关SFTS的文献,导入CiteSpace.5.7.R2软件,以国家、作者、文献共被引、关键词为节点进行可视化分析,并绘制相关图谱。结果?在WOS核心合集共检索到797篇文献,在CNKI数据库共检索到714篇文献。相关领域发文量总体呈上升趋势,中国发文量居首位,美国和日本之间机构合作密切。研究热点集中在发病机制、抗体、特异性治疗等领域。非结构蛋白、临床预后、血小板减少、SFTS感染的靶细胞等将是未来的研究重点。结论?国内外关于SFTS的研究逐渐成熟,新型布尼亚病毒、免疫功能、预后是研究重点,但是对SFTS发病机制和病毒受体尚不清楚,仍须进一步探索。 相似文献
2.
[摘要] 目的 对发热伴血小板减少综合征(severe fever with thrombocytopenia syndrome, SFTS)的相关文献进行文献计量学和可视化分析,探寻近年来的研究现状、热点及趋势,为临床治疗和基础研究提供参考。方法?以Web of Science(WOS)核心合集和中国知网(China national knowledge infrastructure, CNKI)数据库为文献来源,检索2011年1月1日—2021年12月31日有关SFTS的文献,导入CiteSpace.5.7.R2软件,以国家、作者、文献共被引、关键词为节点进行可视化分析,并绘制相关图谱。结果?在WOS核心合集共检索到797篇文献,在CNKI数据库共检索到714篇文献。相关领域发文量总体呈上升趋势,中国发文量居首位,美国和日本之间机构合作密切。研究热点集中在发病机制、抗体、特异性治疗等领域。非结构蛋白、临床预后、血小板减少、SFTS感染的靶细胞等将是未来的研究重点。结论?国内外关于SFTS的研究逐渐成熟,新型布尼亚病毒、免疫功能、预后是研究重点,但是对SFTS发病机制和病毒受体尚不清楚,仍须进一步探索。 相似文献
3.
目的 调查研究刚果(金)维和任务区隐翅虫皮炎患者的发病特点、行为因素及临床治疗情况,为科学防控隐翅虫皮炎提供有效依据。方法 选择2018年5月—2020年4月在刚果(金)维和任务区中国二级医院临床诊断的52例隐翅虫皮炎患者为研究对象,对患者的一般资料、行为因素及临床特征进行流行病学调查,并分析药物的临床疗效。结果 刚果(金)任务区的隐翅虫皮炎具有明显的季节性,每年自10月起发病数逐渐增多,次年1—3月为高峰期。患者驻地主要分布在郊区,有50例(96.15%),多见于户外工作者,为48例(92.3%), 其中白天有明确隐翅虫接触史者21例(40.4%),夜间开窗就寝者20例(38.5%),夜间开荧光灯就寝者16例(30.8%),未使用纱窗者18例(34.6%),就寝时四肢裸露者15例(28.9%),所有患者未使用蚊帐、驱蚊剂及防护服。颈部、前臂为最容易发生的部位;皮损主要呈斑片状红斑分布(80.77%),并可见特征性条索状或“吻唇样”改变。患者自觉烧灼痛(88.46%),少数为瘙痒感(11.54%)。常规予以5%碳酸氢钠溶液擦洗,口服抗组胺药、外用炉甘石洗剂、抗生素联合糖皮质激素软膏是有效治疗手段。对于眶周受累患者,口服强的松,用丁苯羟酸乳膏,获得良好效果。结论 掌握隐翅虫皮炎的流行病学特点,增强二级医院医护人员对隐翅虫皮炎的认识水平,准确识别临床特征,有助于早期诊断并选择合适的治疗方案。 相似文献
4.
目的 分析总结南宁市江南区2019年登革热流行病学特征和疫情应急处置的工作情况,为今后有效地防制登革热提供对策、参考和技术支持。方法 收集南宁市江南区2019年登革热疫情相关数据,评价本次应急处置的工作成效。结果 2019年南宁市江南区登革热疫情严峻,共报告登革热病例370例,其中输入病例4例,本地病例366例;感染人数以家务待业和离退休者居多;男女性别比为1∶1.12;发病年龄最小1岁,最大92岁;发病的空间分布呈现高度聚集,福建园街道占本城区本地病例的87.70%。早期伊蚊应急监测布雷图指数和账诱指数合格率偏低,分别为72.17%和62.61%。针对本次疫情特性,制定有针对性的防控策略,做好精准疫情应急处置,有效压低峰值,迅速控制了疫情的扩散和蔓延。结论 本次疫情是由输入性病例导致本地病例社区水平暴发,疫情呈现多点暴发及扩散蔓延态势。需做好疫情研判、预警预测,准确分析流行病学特征,尽早实施登革热应急处置,精准防控、孳生地处理、健康宣教和病例管理是应急处置的关键措施。 相似文献
5.
目的 分析初治菌阴肺结核患者就诊延迟现况及临床特征,为制定有效措施提供科学依据。方法 应用横断面研究,收集苏州市5家结核病定点医院初治菌阴肺结核患者人口学、经济来源、生活方式、结核病知识、主要病史及进入结核病定点医院前发病和就诊等临床资料,采用Logistic回归方法进行统计分析。结果 379例初治菌阴肺结核患者就诊延迟186例,就诊延迟率为49.08%。老年人(OR=1.898,95% CI=1.157~3.112,P=0.011)、日工作时间大于8 h(OR=1.774,95% CI=1.014~3.102, P=0.044)、流动人口(OR=3.252; 95% CI=1.807~5.855, P<0.001)和发热(OR= 2.061,95% CI=1.021~4.160,P=0.043)是初治菌阴肺结核患者发生就诊延迟的危险特征,而咯血(OR= 0.356, 95% CI= 0.164~0.773,P=0.009)是就诊延迟的保护特征。结论 初治菌阴肺结核患者就诊延迟现象较严重,需对不同临床特征的患者采取综合干预措施,减少就诊延迟发生。 相似文献
6.
7.
《Vaccine》2022,40(26):3490-3494
The current WHO Recommendations to assure the quality, safety and efficacy of live attenuated yellow fever vaccines were adopted in 2010. This document recommends that vaccine virus master and working seed lots should be tested for viscerotropism, immunogenicity and neurovirulence in monkeys. A vaccine manufacturer has reported, recently, discrepancies on the clinical scoring of monkeys during assessment of working seed lots and suggested aligning neurotropism assessment of yellow fever vaccines virus seed lots with that of neurovirulence testing of polio vaccines virus seed lots. In this approach, clinical signs are recorded but do not form part of the assessment or pass/fail criteria. At its 71st meeting in August 2020, the ECBS agreed to establish a drafting group and to consult with manufacturers and other stakeholders on the proposed amendment. Then a survey had been conducted to seek opinions of stakeholders on the neurotropism testing and revision of current WHO Recommendations for yellow fever vaccines. It was recognized from the answers of the survey that the test for neurovirulence in monkeys presents several technical challenges which could be addressed in the amended version of the Recommendations.On 18–19 March 2021, a virtual WHO working group meeting was held to discuss a proposed draft of the amended text with participants of yellow fever vaccine manufacturers and relevant regulators. Overall, there was a consensus among manufacturers and regulators that clinical evaluation provides important information and should be retained as part of the neurotropism test. However, there was also agreement that the test is somewhat subjective, and that analysis can be difficult. It was recognized that there was potential for improvement in both test execution and analysis to increase harmonization between manufacturers. Alternative tests to the non-human primates neurovirulence test would be useful but it was agreed that none seem to be sufficiently developed at present. Based on these working group discussions, it was proposed that the appendix on neurotropism test to be further revised by the WHO drafting group and submitted to ECBS for review and adoption.Issues other than neurotropism test were discussed in the meeting as well. There were a number of points identified during the meeting, such as new platform of production, animal models, deep sequencing, international standards, that are outside the current recommendations that are worthy of further discussion. Therefore, it is recommended that there would be a future meeting with various stakeholders to discuss the potential revision of the whole Recommendations for yellow fever vaccines in order to meet the current needs. 相似文献
8.
As a result of unprecedented spread of African swine fever (ASF) since 2018, Canada has taken additional steps to prevent introduction of the virus. While the role of plant-based feed in the transmission of ASF is not completely understood, it was identified that no mitigation measures were in place to address this uncertain risk. A risk analysis process was conducted with collaboration between government and industry, including an assessment of the costs and benefits of various risk mitigation options. Using existing legislative tools, requirements must now be met before the importation of plant-based feed ingredients of concern is permitted. Even with an uncertain risk, countries such as Canada that would suffer severe consequences should ASF be introduced, need to consider appropriate, risk-based mitigation measures. 相似文献
9.
Rachel A. Schambow Fernando Sampedro Pedro E. Urriola Jennifer L. G. van de Ligt Andres Perez Gerald C. Shurson 《Transboundary and Emerging Diseases》2022,69(1):157-175
Economically relevant pathogens, such as African swine fever virus (ASFV), have been shown to survive when experimentally inoculated in some feed ingredients under the environmental conditions in transoceanic transport models. However, these models did not characterize the likelihood of virus survival under various time and temperature processes that feed ingredients undergo before they are added to swine diets. Here, we developed a quantitative risk assessment model to estimate the probability that one or more corn or soybean meal ocean vessels (25,000 tonnes) contaminated with ASFV would be imported into the United States annually. This final probability estimate was conditionally based on five likelihoods: the probability of initial ASFV contamination (p0), ASFV inactivation during processing (p1) and transport (p2), recontamination (pR), and ASFV inactivation while awaiting customs clearance at United States entry (p3). The probability of ASFV inactivation was modelled using corn and soybean (extruded or solvent extracted) processing conditions (times and temperatures), D-values (time to reduce 90% or 1-log) estimated from studies of ASFV thermal inactivation in pork serum (p1), and survival in feed ingredients during transoceanic transport (p2 and p3). ‘What-if’ scenarios using deterministic values for p0 and pR (1%, 10%, 25%, 50%, 75%, and 100%) were used to explore their impact on risk. The model estimated complete inactivation of ASFV after extrusion or solvent extraction processes regardless of the initial ASFV contamination probability assumed. The value of recontamination (ranging from 1% to 75%) was highly influential on the risk of one ASFV-contaminated soybean meal vessel entering the United States. Median risk estimates ranged from 0.064% [0.006%–0.60%; 95% probability interval (PI)], assuming a pR of 1.0%, up to 4.67% (0.45%–36.50% 95% PI) assuming a pR of 75.0%. This means that at least one vessel with ASFV-contaminated soybean meal would be imported once every 1563–21 years, respectively. When all raw corn was assumed to be contaminated (p0 = 100%), and no recontamination was assumed to occur (pR = 0%), the median probability of one vessel with ASFV-contaminated corn entering the United States was 2.02% (0.28%–9.43% 95% PI) or once every 50 years. Values of recontamination between 1% and 75% did not substantially change the risk of corn. Days of transport, virus survival during transport (D-value), and number of vessels shipped were the parameters most influential for increased likelihood of a vessel with ASFV-contaminated soybean meal or corn entering the United States. The model helped to identify knowledge gaps that are most influential on output values and serves as a framework that could be updated and parameterized as new scientific information becomes available. We propose that the quantitative risk assessment model developed in this study can be used as a framework for estimating the risk of ASFV entry into the United States and other ASFV-free countries through other types of imported feed ingredients that may potentially become contaminated. Ultimately, this model can be used to develop risk mitigation strategies and critical control points for inactivating ASFV during feed ingredient processing, storage, and transport, and contribute to the design and implementation of biosecurity measures to prevent the introduction of ASFV into the United States and other ASFV-free countries. 相似文献
10.
Q热是由贝纳柯克斯体感染引起的人畜共患疾病,临床表现可引起肺炎、肝炎、心肌炎、心内膜炎等,但合并横纹肌溶解病例相对少见。贝纳柯克斯体感染诊断相对困难,而高通量测序,包括纳米孔三代测序(ONT)在内,可作为诊断Q热较为敏感的检测方法,早期诊断和及时治疗,一般Q热预后良好。本文报告1例经ONT检测确诊为急性Q热合并横纹肌溶解的病例,该病例经治疗后病情好转出院。 相似文献